Client News
Filter by:
- May 9 2022 Adamis Pharmaceuticals Schedules First Quarter 2022 Financial Results Conference Call and Business Update
- May 9 2022 Genprex's Chief Medical Officer to Be Featured as an Expert Panelist at the 33rd Annual Cancer Progress Conference
- May 5 2022 Prothena Reports First Quarter 2022 Financial Results and Business Highlights
- May 5 2022 NetCents Technology Announces an Update on the Annual Audit
- May 5 2022 NetCents Technology Announces an Update on the Annual Audit
- May 5 2022 Anixa Biosciences to Present at the 2022 H.C. Wainwright Global Investment Conference
- May 5 2022 Genprex Issues Shareholder Letter and Provides 2022 Corporate Update
- May 5 2022 Processa Pharmaceuticals to Host Conference Call to Discuss First Quarter 2022 Results and Provide Drug Development Update on May 12, 2022 at 4:30 p.m. EST
- May 5 2022 Salarius Pharmaceuticals to Report First Quarter 2022 Financial Results and Highlight Recent Company Progress
- May 5 2022 KemPharm Announces Submission of Investigational New Drug Application for Phase 2 Trial of KP1077 in Idiopathic Hypersomnia (IH)